<DOC>
	<DOCNO>NCT00699010</DOCNO>
	<brief_summary>The purpose study : ( 1 ) ass effect oxycodone HCl niacin-induced dysphoric effect oxycodone HCl administer combination niacin subject history opioid abuse ; ( 2 ) ass abuse liability 4 time usual recommend dose Acurox ( oxycodone HCl 40 mg plus niacin 240 mg ) versus oxycodone HCL 40 mg alone subject history opioid abuse .</brief_summary>
	<brief_title>Study Abuse Liability Oxycodone HCl/Niacin Subjects With History Opioid Abuse</brief_title>
	<detailed_description />
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<mesh_term>Oxycodone</mesh_term>
	<criteria>Subject male female 18 55 year age Subject meet DSMIV Criteria Diagnosis Opioid Substance Abuse subject unlikely experience idiosyncratic reaction respiratory depression ingest 40 mg oxycodone Body weight 20 % ideal body weight Subject agrees abstain Rx OTC drug ( except authorize Investigator ) alcohol Subject generally good health Subject reliable , willing , cooperative , able communicate effectively , minimum 6th grade read level Subject acceptable score MMSE cognitive impairment For woman childbearing potential : woman pregnant nursing , practice acceptable method birth control Subject disease may endanger subject validity data Subject currently physically dependent opiate alcohol Subject expose investigational drug within 30 day prior inpatient phase Subject history hypersensitivity drug , know allergy component study drug formulation Subject positive urine drug screen nonopiate drug Subject predispose condition may place subject risk receive niacin oxycodone , confound study analysis Subject ingest niacin dos higher SDI within 14 day prior inpatient phase Subject abnormal bleeding tendency</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Abuse Liability</keyword>
	<keyword>Abuse Prevention</keyword>
	<keyword>Abuse Resistance</keyword>
	<keyword>Abuse Deterrence</keyword>
</DOC>